Urgent action needed to combat AMR and achieve EU’s 2030 targets

Between 2019 and 2023, antibiotic consumption in the EU increased by 1%, moving further away from the 2030 target of a 20% reduction recommended by the Council of the European Union.

JP Morgan 2025: Eli Lilly misses 2024 revenue estimate by $400m – Pharmaceutical Technology

Lilly plans to share its full Q4 2024 results on 6 February 2025. Credit: JHVEPhoto via Getty Images. Eli Lilly has announced a $400m reduction

January 15, 2025

AbbVie drops two early-stage ADCs, including Pfizer-partnered oncology program

AbbVie removed two early-stage antibody-drug conjugates from its pipeline, per a Wednesday update to its pipeline webpage. The Chicago-area Big Pharma culled ABBV-011 and the

August 25, 2023

Cybin Completes Acquisition of Small Pharma Inc. to Create International Clinical-stage Leader in Novel Psychedelic Therapeutics | Psychedelic Invest

–Combined portfolios create the industry’s largest, most advanced, well-protected deuterated DMT program – – Combination creates the largest intellectual property portfolio in the psychedelic drug

October 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.